Jade Biosciences (JBIO) Operating Leases (2021 - 2026)
Jade Biosciences (JBIO) posted Operating Leases of $628,000 for Q2 2026, down 21.5% from $800,000 a year earlier and down 10.3% from the prior quarter.
Powered by 
Analysis
Jade Biosciences (JBIO) Operating Leases (2021 - 2026) Analysis & Trends
At the end of FY2025, Jade Biosciences' Operating Leases came in at $724,000.
- Annual Operating Leases shows a four-year compound annual growth rate of 17.3% (FY2021 to FY2025).
- In prior years, Jade Biosciences' Operating Leases was $255,000 in FY2023 (-63.8%), $705,000 in FY2022 (+84.6%) and $382,000 in FY2021.
- The Q2 2026 figure stands as the lowest quarterly Operating Leases since Q3 2024.
- On a year-over-year basis, Operating Leases increased in two of the last four quarters, with growth averaging 252.9%.
- The strongest year-over-year quarter for Operating Leases in the past five years was Q3 2025, with growth of 822.2%; the weakest was Q3 2024, with a decline of 77.4%.
- According to Business Quant data, Operating Leases for the three prior quarters was $700,000 (Q1 2026), $724,000 (Q4 2025) and $747,000 (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn |
| 10 | Jade Biosciences | 912.03 Mn | 912.03 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 628,000.00 |
| Mar 31, 2026 | 700,000.00 |
| Dec 31, 2025 | 724,000.00 |
| Sep 30, 2025 | 747,000.00 |
| Jun 30, 2025 | 800,000.00 |
| Sep 30, 2024 | 81,000.00 |
| Jun 30, 2024 | 206,000.00 |
| Mar 31, 2024 | 329,000.00 |
| Dec 31, 2023 | 255,000.00 |
| Sep 30, 2023 | 358,000.00 |
| Jun 30, 2023 | 476,000.00 |
| Mar 31, 2023 | 591,000.00 |
| Dec 31, 2022 | 705,000.00 |
| Sep 30, 2022 | 800,000.00 |
| Jun 30, 2022 | 862,000.00 |
| Mar 31, 2022 | 335,000.00 |
| Dec 31, 2021 | 382,000.00 |
| Sep 30, 2021 | 452,000.00 |
API Access
Jade Biosciences Operating Leases API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=operating-leases&ticker=JBIO&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "operating-leases", "ticker": "JBIO", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=operating-leases&ticker=JBIO&period=max&api_key=YOUR_API_KEY");
const data = await res.json();